Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122907903 | 12290790 | 3 | F | 201606 | 20160809 | 20160421 | 20160812 | PER | US-PFIZER INC-2016209413 | PFIZER | 79.00 | YR | F | Y | 0.00000 | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122907903 | 12290790 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (4 WEEKS ON AND 1 WEEK OFF) | 21938 | 25 | MG | CAPSULE, HARD | ||||||||
| 122907903 | 12290790 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, 1X/DAY | 21938 | 37.5 | MG | CAPSULE, HARD | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122907903 | 12290790 | 1 | Renal cancer stage IV |
| 122907903 | 12290790 | 2 | Renal cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122907903 | 12290790 | Agitation | |
| 122907903 | 12290790 | Formication | |
| 122907903 | 12290790 | Insomnia | |
| 122907903 | 12290790 | Malaise | |
| 122907903 | 12290790 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122907903 | 12290790 | 1 | 20160330 | 0 | ||
| 122907903 | 12290790 | 2 | 20160610 | 0 |